dc.contributor.author | Aucoin, Monique | |
dc.contributor.author | Cooley, Kieran | |
dc.contributor.author | Saunders, Paul Richard | |
dc.contributor.author | Carè, Jenny | |
dc.contributor.author | Anheyer, Dennis | |
dc.contributor.author | Medina, Daen N | |
dc.contributor.author | Cardozo, Valentina | |
dc.contributor.author | Remy, Daniella | |
dc.contributor.author | Hannan, Nicole | |
dc.contributor.author | Garber, Anna | |
dc.date.accessioned | 2020-08-19T00:54:08Z | |
dc.date.available | 2020-08-19T00:54:08Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 2212-9588 | |
dc.identifier.doi | 10.1016/j.aimed.2020.07.004 | |
dc.identifier.uri | http://hdl.handle.net/10072/396535 | |
dc.description.abstract | Brief overview:
Current evidence suggests that Echinacea supplementation may decrease the duration and severity of acute respiratory tract infections; however, no studies using Echinacea in the prevention or treatment of conditions similar to COVID-19 have been identified. Few adverse events were reported, suggesting that this herbal therapy is reasonably safe. Because Echinacea can increase immune function, there is a concern that it could worsen over-activation of the immune system in cytokine storm; however, clinical trials show that Echinacea decreases levels of immune molecules involved in cytokine storm.
Verdict:
Echinacea supplementation may assist with the symptoms of acute respiratory infections (ARI) and the common cold, particularly when administered at the first sign of infection; however, no studies using Echinacea in the prevention or treatment of conditions similar to COVID-19 have been identified. Previous studies have reported that Echinacea may decrease the severity and/or duration of ARI when taken at the onset of symptoms. The studies reporting benefit used E. purpurea or a combination of E. purpurea and E. angustifolia containing standardized amounts of active constituents.
Few adverse events from the use of Echinacea were reported, suggesting that this herbal therapy is reasonably safe. No human trials could be located reporting evidence of cytokine storm when Echinacea was used for up to 4 months.
When assessing all human trials which reported changes in cytokine levels in response to Echinacea supplementation, the results were largely consistent with a decrease in the pro-inflammatory cytokines that play a role in the progression of cytokine storm and Acute Respiratory Distress Syndrome (ARDS), factors that play a significant role in the death of COVID-19 patients. While there is currently no research on the therapeutic effects of Echinacea in the management of cytokine storm, this evidence suggests that further research is warranted. | |
dc.description.peerreviewed | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofjournal | Advances in Integrative Medicine | |
dc.subject.fieldofresearch | Infectious diseases | |
dc.subject.fieldofresearch | Traditional, complementary and integrative medicine | |
dc.subject.fieldofresearch | Nutrition and dietetics | |
dc.subject.fieldofresearch | Health services and systems | |
dc.subject.fieldofresearch | Public health | |
dc.subject.fieldofresearchcode | 320211 | |
dc.subject.fieldofresearchcode | 4208 | |
dc.subject.fieldofresearchcode | 3210 | |
dc.subject.fieldofresearchcode | 4203 | |
dc.subject.fieldofresearchcode | 4206 | |
dc.title | The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dcterms.bibliographicCitation | Aucoin, M; Cooley, K; Saunders, PR; Carè, J; Anheyer, D; Medina, DN; Cardozo, V; Remy, D; Hannan, N; Garber, A, The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review, Advances in Integrative Medicine, 2020 | |
dcterms.license | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.date.updated | 2020-08-18T03:58:36Z | |
dc.description.version | Accepted Manuscript (AM) | |
gro.description.notepublic | This publication has been entered in Griffith Research Online as an advanced online version. | |
gro.rights.copyright | © 2020 The American Association of Orthodontistsr. Published by Elsevier Ltd. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Hannan, Nicole | |